Hamburg: FDA could have acted more aggressively with compounders

Testifying at a House hearing Tuesday, FDA Commissioner Dr. Margaret Hamburg admitted that her agency could have acted more aggressively against the New England Compounding Center, a pharmacy tied to a deadly meningitis outbreak last fall. "I think we allowed ourselves to be far too cautious because of fears of litigation that might further undermine our authority," Hamburg said. She also repeated concerns about the FDA's lack of influence over these pharmacies, saying it needs greater authority to make compounders follow tighter standards of safety.

View Full Article in:

New York Times (tiered subscription model), The · Hill, The · Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA